C H Robinson Worldwide Inc SEC Filings

Form 144 notice for C.H. Robinson Worldwide, Inc. (CHRW) reports a proposed open‑market sale of 266,732 common shares on 08/27/2025 through Charles Schwab. The filing shows an aggregate market value of $34,080,348 and 118,091,162 shares outstanding, indicating the sale is a small fraction of total shares. The shares being offered were acquired in two open‑market purchases on 02/23/2022 (116,100 shares) and 02/24/2022 (150,632 shares), with broker checks used for payment. The filer states there were no securities sold in the past three months for the account and attests not to possessing undisclosed material adverse information.

Rajan Arun, Chief Strategy & Innovation Officer of C.H. Robinson Worldwide, Inc. (CHRW), reported a sale of 2,500 shares of common stock on 08/15/2025 at a price of $121.74 per share. The filing states the sale was made pursuant to a 10b5-1(c) plan adopted on 05/08/2025. After the reported transaction, the reporting person beneficially owns 130,591 shares, which the filing explains include 91,210 shares issuable on settlement of restricted stock units and deferred shares credited to a NQDC plan account and 38,994 shares held directly; an additional 387 shares were acquired under the employee stock purchase plan. The form is signed by an attorney-in-fact and contains only the insider transaction and ownership breakdown disclosed above.

C.H. Robinson Worldwide, Inc. (CHRW) filed a Form 144 notifying the proposed sale of 2,500 common shares through Fidelity Brokerage Services with an aggregate market value of $304,350.00. The filing lists approximately 118,091,162 shares outstanding and an approximate sale date of 08/15/2025 on NASDAQ. The shares were acquired on 09/01/2022 upon restricted stock vesting from the issuer and were received as compensation. The filer reports no sales of the issuer's securities in the past three months. Several filer identification fields in the provided content (including CIK and contact details) appear blank in the copy provided.

Insider sale reported by Angela K. Freeman, CHRO and ESG Officer of C.H. Robinson Worldwide (CHRW). The Form 4 discloses that on 08/11/2025 Freeman disposed of 5,713 shares of CHRW common stock in multiple transactions at a weighted average price of $116.243 per share, with sale prices ranging from $116.11 to $116.48.

After the reported sale the reporting person beneficially owns 65,728 shares, comprised of 65,459 shares issuable upon settlement of restricted stock units and deferred plan credits and 269 shares held directly. No derivative securities were reported and the Form 4 was filed by one reporting person.

Edward G. Feitzinger, a director of C.H. Robinson (CHRW), was granted 1,270 restricted stock units (phantom shares) on 08/07/2025 as a pro-rated portion of the annual equity-based award for non-employee directors. Each unit will be paid in one share of common stock. The restricted stock units are immediately vested and, following the reporting person's termination of service as a director, become payable in shares according to the payment schedule previously chosen by the reporting person. The grant is reported as a direct acquisition of derivative securities at a $0 price.

C.H. Robinson amended its receivables purchase agreement to extend the securitization facility's termination date to August 12, 2027, while the committed funding available to its bankruptcy-remote subsidiary, C.H. Robinson Receivables, LLC, remains unchanged at $500 million. This amendment preserves the company's existing receivables financing capacity and maintains an off-balance-sheet funding source used to support working capital and payments to freight carriers.

The report also supplements a prior disclosure that Edward G. Feitzinger was elected to the board and will receive the company’s standard non-employee director compensation per the 2025 proxy; committee assignments are not yet determined. The amendment is filed as Exhibit 10.1.

C.H. Robinson Worldwide, Inc. (CHRW) filed a Form 144 notifying a proposed sale of 5,713 common shares with an aggregate market value of $664,096.36. The notice identifies Fidelity Brokerage Services LLC as the broker and lists the approximate date of sale as 08/11/2025 on NASDAQ. The filing states total shares outstanding of 118,091,162.

The securities to be sold were acquired through employee stock purchase plan purchases on multiple dates (2019–2023) and restricted stock vesting in 2022 and 2024, with listed lots including 894 and 4,156 shares from vesting. The filing also reports a prior sale on 05/14/2025 of 5,700 shares by the Angela K Freeman Revocable Trust for $555,322.50.